Seeman-Lodding H, Biber B, Martner J, Pontén J, Winsö O
Department of Anesthesiology, Ostra University Hospital, Gothenburg, Sweden.
Acta Anaesthesiol Scand. 1996 Apr;40(4):408-15. doi: 10.1111/j.1399-6576.1996.tb04461.x.
Pharmacological control of blood pressure is usually indicated during aortic cross-clamping (AXC). The aim of this study was to analyze the modulation by isoflurane (ISO), sodium nitroprusside (SNP) and milrinone (MIL) of the systemic circulatory responses to a standardized infra-renal AXC.
Chloralose-anaesthetized pigs were exposed to AXC at control (no vasoactive drugs) and during the administration of each of the drugs.
During control, AXC increased mean arterial pressure (MAP, 17 +/- 4%) and systemic vascular resistance (SVR, 27 +/- 7%), but induced no significant changes in cardiac output (CO), heart rate (HR), pulmonary arterial pressures, pulmonary vascular resistance or central venous pressure. Low-dose ISO (0.7%) and investigated doses of SNP and MIL did not significantly alter this response. High-dose ISO (1.4%, attenuated the AXC-induced increase in SVR, but not in MAP. All drugs decreased non-clamp MAP levels. Therefore, with low-dose ISO and with SNP or MIL, peak MAP during AXC was not significantly different from control non-clamp levels (i.e. prior to pharmacological or surgical interventions). High-dose ISO was associated with a MAP during AXC that was below control non-clamp levels.
The objective that during AXC MAP should not exceed control non-clamp levels was achieveable by ISO, SNP or MIL. The modulating actions of the drugs on MAP during AXC were exerted mainly through reductions in non-clamp levels. This systemic hypotension was associated with decreased CO and SVR during ISO, and with decreased SVR and increased HR during SNP and MIL. Attenuation of the AXC-induced increase in SVR was produced only by 1.4% ISO.
在主动脉交叉钳夹(AXC)期间通常需要进行血压的药物控制。本研究的目的是分析异氟烷(ISO)、硝普钠(SNP)和米力农(MIL)对标准化肾下AXC引起的全身循环反应的调节作用。
用氯醛糖麻醉猪,在对照(不使用血管活性药物)以及给予每种药物期间进行AXC。
在对照期间,AXC使平均动脉压(MAP,升高17±4%)和全身血管阻力(SVR,升高27±7%),但对心输出量(CO)、心率(HR)、肺动脉压、肺血管阻力或中心静脉压无显著影响。低剂量ISO(0.7%)以及所研究剂量的SNP和MIL并未显著改变这种反应。高剂量ISO(1.4%)减弱了AXC引起的SVR升高,但未减弱MAP升高。所有药物均降低了非钳夹状态下的MAP水平。因此,使用低剂量ISO以及SNP或MIL时,AXC期间的MAP峰值与对照非钳夹水平(即药物或手术干预前)无显著差异。高剂量ISO使AXC期间的MAP低于对照非钳夹水平。
ISO、SNP或MIL可实现AXC期间MAP不超过对照非钳夹水平的目标。这些药物在AXC期间对MAP的调节作用主要通过降低非钳夹水平来实现。这种全身性低血压在ISO期间与CO和SVR降低有关,在SNP和MIL期间与SVR降低和HR升高有关。仅1.4%的ISO可减弱AXC引起的SVR升高。